ClinicalTrials.gg
RecruitingNCT07125794Updated Aug 15, 2025

Original Denis Brawn Brace Versus Its Modification for Management of Relapsed Idiopathic Clubfoot Following Ponseti Casting

An observational study in Denis Brawn Brace, Modification and Management, sponsored by The General Authority for Teaching Hospitals and Institutes. Recruiting at 1 site in Egypt. Open to participants aged 2 Years to 5 Years. Per ClinicalTrials.gov, last updated 2025-08-15.

Sponsored by The General Authority for Teaching Hospitals and Institutes · Observational

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
60
Ages
2 Years to 5 Years
Sex
All
01

Study summary

This study aims to compare the effectiveness of the original Denis Brawn brace to its modification in managing relapsed idiopathic clubfoot in patients following Ponseti casting.

Read the detailed description

Clubfoot is an intricate deformity of the ankle and foot involving bony malalignment, adduction of the forefoot, and hindfoot varus, cavus, and equinus caused by contracture of soft tissues.

Lack of compliance causes the majority of relapse, as the child may have problems sleeping and wearing the Dennis Brown Splint; that is why parental counseling is vital and very much important in this regard.

Bracing plays a vital role in the maintenance of corrected club foot and allows the foot to achieve normal position after tenotomy, followed by serial casting. Bracing holds the foot not in a corrected but in an overcorrected position so that the normal position of the foot could be achieved after the correction. Without bracing, it is almost impossible for the physician or the surgeon to maintain the correction.

02

Conditions studied

  • Denis Brawn Brace
  • Modification
  • Management
  • Idiopathic Clubfoot
  • Ponseti Casting

Browse trials for

03

In context

Clubfoot

69 studies on the registry are indexed under Clubfoot; 15 are open to participants now.

This study's planned enrollment of 60 is close to the median of 55 across 27 observational studies indexed under Clubfoot.

Browse Clubfoot studies →

Lead sponsor

The General Authority for Teaching Hospitals and Institutes is the lead sponsor of 8 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This retrospective study will be carried out on 60 patients with idiopathic clubfoot after approval from the institutional ethical committee.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age from 2 to 5 years.
  • Both sexes.
  • cases.
  • Patients with idiopathic clubfoot.

Exclusion criteria

Exclusion Criteria:

  • Neurological or syndromic involvement.
  • Presenting with skin or soft-tissue lesions around the foot and ankle.
  • Inadequate documentation.
  • Soft-tissue surgery is needed (except tendo-achilles tenotomy).
  • Irregular plaster casting schedule.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Relapsed and refractory

Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group I

    Patients who were managed with the original Denis Browne splint.

    Procedure: Original Denis Browne splint

  • Group II

    Patients who were managed with the modified Denis Browne splint.

    Procedure: Modified Denis Browne splint

Interventions

  • ProcedureOriginal Denis Browne splint

    Patients who were managed with the original Denis Browne splint.

  • ProcedureModified Denis Browne splint

    Patients who were managed with the modified Denis Browne splint.

06

What researchers measure

Primary outcomes

  1. Parents' compliance

    Parents' compliance will be classified into three grades as follows: * Grade 0: poor follow-up with a lack of commitment in bracing hours (bad compliance). * Grade 1: an intermittent follow-up with a good commitment in bracing hours (intermediate compliance). * Grade 2: a good follow-up with a strict commitment in bracing hours (good compliance).

    Time frame: 12 months post-procedure

Secondary outcomes

  1. Efficacy in maintaining correction measured by the Pirani score

    The Pirani scoring system is reliable, quick, and easy to use, and provides a good forecast about the likely treatment for an individual foot. It involves evaluating six clinical signs of contracture, with scores ranging from 0 to 1 for each sign, and a higher score indicating a more severe deformity. All the patients treated will undergo thorough evaluation to find out other systemic diseases, and grading of the feet as per the modified Pirani scoring system.

    Time frame: 12 months post-procedure

  2. Incidence of complications

    Incidence of complications will be recorded.

    Time frame: 12 months post-procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for May 2026, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 10, 2025
First posted
Aug 15, 2025
StartActual
May 1, 2025
Primary completionEst.
May 1, 2026
CompletionEst.
May 1, 2026
Last update
Aug 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07125794
Lead sponsor
The General Authority for Teaching Hospitals and Institutes
Responsible party
Mahmoud Mohamed Abdallah (Orthopedic Surgery, The General Authority for Teaching Hospitals and Institutes) — Principal investigator
First posted
Aug 15, 2025
Start date
May 1, 2025
Primary completion
May 1, 2026 (estimated)
Completion
May 1, 2026 (estimated)
Last update
Aug 15, 2025

Study contacts

Mahmoud M Abdallah, MD
Contact
Mma-ortho@hotmail.com
00201006194146

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion